14.01
price up icon7.11%   0.93
after-market Handel nachbörslich: 14.19 0.18 +1.28%
loading

Summit Therapeutics Inc Aktie (SMMT) Neueste Nachrichten

pulisher
11:36 AM

Summit Therapeutics (SMMT) Raises $500 Million Through Public Offering - Insider Monkey

11:36 AM
pulisher
10:41 AM

Insider Buying: Summit Therapeutics Co-CEO, President & Director Bought US$1.5m Of Shares - simplywall.st

10:41 AM
pulisher
03:00 AM

Summit Therapeutics files for $500M common stock offering; shares slide over 9% - MSN

03:00 AM
pulisher
Jun 12, 2026

Summit Therapeutics (SMMT) Shares Rebound After Co-CEO's $50M St - GuruFocus

Jun 12, 2026
pulisher
Jun 12, 2026

5 Best Buy-the-Dip Stocks to Invest In Now - Insider Monkey

Jun 12, 2026
pulisher
Jun 12, 2026

Summit rebounds after nearly $50M insider purchase - MSN

Jun 12, 2026
pulisher
Jun 12, 2026

SMMT Jumps As Ivonescimab Trial Success Fuels Financing Drive - StocksToTrade

Jun 12, 2026
pulisher
Jun 12, 2026

Summit Therapeutics (NASDAQ: SMMT) investors approve directors and 8M-share incentive plan boost - Stock Titan

Jun 12, 2026
pulisher
Jun 12, 2026

Summit Therapeutics co-CEO Zanganeh acquires $49.98m in shares By Investing.com - Investing.com India

Jun 12, 2026
pulisher
Jun 12, 2026

Summit Therapeutics(SMMT.US) 10% Shareholder Buys US$49.99 Million in Common Stock - Moomoo

Jun 12, 2026
pulisher
Jun 12, 2026

Insider Stock Purchases: June 12, 2026 - Quiver Quantitative

Jun 12, 2026
pulisher
Jun 12, 2026

Summit Therapeutics co-CEO Zanganeh acquires $49.98m in shares - Investing.com

Jun 12, 2026
pulisher
Jun 12, 2026

Co-CEO Mahkam Zanganeh (SMMT) reports spouse’s 3.81M-share open-market buy - Stock Titan

Jun 12, 2026
pulisher
Jun 12, 2026

Summit gains after nearly $50M insider buy (SMMT:NASDAQ) - Seeking Alpha

Jun 12, 2026
pulisher
Jun 12, 2026

Summit Therapeutics stock rises after CEO share purchase By Investing.com - Investing.com Canada

Jun 12, 2026
pulisher
Jun 12, 2026

Summit Therapeutics Insider Bought Shares Worth $49,987,200, According to a Recent SEC Filing - Moomoo

Jun 12, 2026
pulisher
Jun 12, 2026

Summit Therapeutics stock rises after CEO share purchase - Investing.com

Jun 12, 2026
pulisher
Jun 12, 2026

Summit Therapeutics co-CEO Robert Duggan buys $49.9m in stock - Investing.com India

Jun 12, 2026
pulisher
Jun 12, 2026

Summit Therapeutics co-CEO Robert Duggan acquires 3.81 million shares - StreetInsider

Jun 12, 2026
pulisher
Jun 12, 2026

Summit Therapeutics Co-Chief Executive Officer Purchased Shares Worth Over $49M - TradingView

Jun 12, 2026
pulisher
Jun 12, 2026

Summit Therapeutics (SMMT) Co-CEO Robert Duggan buys 3.81M shares in open market - Stock Titan

Jun 12, 2026
pulisher
Jun 12, 2026

Summit Therapeutics Halts US$500m Offering After Ivonescimab Trial Results - Yahoo Finance

Jun 12, 2026
pulisher
Jun 12, 2026

Why is SMMT stock tumbling today? - MSN

Jun 12, 2026
pulisher
Jun 11, 2026

Summit Therapeutics (SMMT) Withdraws Public Offering Amid Market Conditions - GuruFocus

Jun 11, 2026
pulisher
Jun 11, 2026

Summit Therapeutics (SMMT) Withdraws $500M Public Offering Amid Market Conditions - GuruFocus

Jun 11, 2026
pulisher
Jun 11, 2026

Summit pulls $500M share sale a day after announcing it - BioPharma Dive

Jun 11, 2026
pulisher
Jun 11, 2026

Summit Therapeutics withdraws proposed securities offering citing market conditions - MSN

Jun 11, 2026
pulisher
Jun 11, 2026

Summit Therapeutics Withdraws Proposed Underwritten Public Offering Effective- SEC Filing - TradingView

Jun 11, 2026
pulisher
Jun 11, 2026

Summit Therapeutics withdraws proposed underwritten offering citing market conditions - TradingView

Jun 11, 2026
pulisher
Jun 11, 2026

Summit Therapeutics (NASDAQ: SMMT) pulls planned stock sale amid markets - Stock Titan

Jun 11, 2026
pulisher
Jun 11, 2026

Summit Therapeutics stock hits 52-week low at 13.14 USD By Investing.com - Investing.com Nigeria

Jun 11, 2026
pulisher
Jun 10, 2026

Summit Therapeutics (SMMT) Sees a 10.2% Decline - GuruFocus

Jun 10, 2026
pulisher
Jun 10, 2026

Oil Jumps On Iran Strikes, Nasdaq 100 Falls On Hot Inflation: Stock Market Today - Benzinga

Jun 10, 2026
pulisher
Jun 10, 2026

Summit Therapeutics stock hits 52-week low at 13.14 USD - Investing.com

Jun 10, 2026
pulisher
Jun 10, 2026

SMMT: All board nominees and proposals were approved; no shareholder questions were raised - TradingView

Jun 10, 2026
pulisher
Jun 10, 2026

Super Micro Computer, Summit Therapeutics And Other Big Stocks Moving Lower In Wednesday's Pre-Market Ses - Benzinga

Jun 10, 2026
pulisher
Jun 10, 2026

Why Is SMMT Stock Tumbling Today? - Asianet Newsable

Jun 10, 2026
pulisher
Jun 10, 2026

Summit Therapeutics plc (SMMT) stock price, news, quote and history - Yahoo Finance UK

Jun 10, 2026
pulisher
Jun 10, 2026

Summit Therapeutics Announces Proposed Public Offering of Common StockJune 9, 2026 - BioSpace

Jun 10, 2026
pulisher
Jun 09, 2026

Summit Therapeutics (SMMT) Launches $500M Public Offering Amid S - GuruFocus

Jun 09, 2026
pulisher
Jun 09, 2026

Summit Therapeutics launches $500 million stock offering By Investing.com - Investing.com South Africa

Jun 09, 2026
pulisher
Jun 09, 2026

[424B5] Summit Therapeutics Inc. Prospectus Supplement (Debt Securities) - Stock Titan

Jun 09, 2026
pulisher
Jun 09, 2026

Summit Therapeutics launches $500 million stock offering - Investing.com

Jun 09, 2026
pulisher
Jun 09, 2026

Summit Therapeutics Launches $500 Million Common Stock Public Offering - Moomoo

Jun 09, 2026
pulisher
Jun 09, 2026

Summit Therapeutics stock tumbles on $500M stock offering By Investing.com - Investing.com South Africa

Jun 09, 2026
$30.04
price up icon 1.04%
$108.53
price up icon 0.65%
$90.54
price up icon 1.12%
$54.87
price down icon 0.76%
ONC ONC
$264.48
price up icon 1.62%
$153.87
price up icon 3.11%
Kapitalisierung:     |  Volumen (24h):